The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biomarker of Disease Market Research Report 2025
Synopsis
Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drug.
The global Biomarker of Disease market was valued at US$ 27750 million in 2023 and is anticipated to reach US$ 78390 million by 2030, witnessing a CAGR of 15.9% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Biomarker of Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker of Disease.
The Biomarker of Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomarker of Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker of Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aushon Biosystem
Bio-Rad Laboratories
Thermo Fisher Scientific Inc
Siemens AG
Eisai Co. Ltd
Roche Diagnostics Limited
Abbott Laboratories, Inc
Epistem Ltd
Ge Healthcare
Agilent Technologies Inc
Segment by Type
Sample Preparation
Assay Development
Biomarker Validation and Testing
Others
Segment by Application
Pharmaceutical Companies
Government & Private Research Institutes
Academic Institutes
Medical Device Manufacturing Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker of Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Omics, proteomics, meta-bolomics technologies are used in biomarkers discovery and disease diagnosis. Biomarkers are used in risk assessment, molecular diagnostic, disease diagnosis, DNA fingerprinting and other molecular applications. Biomarkers enable pharmaceutical companies to analyze and discover novel drugs as demand for cost effective and efficient treatment dose is increasing. Biomarkers are used in drug validation and testing, sample preparation and assay development to eliminate complexity in discovery and development of novel drugs. Biomarkers of disease are used in identification of disease condition and also help in validation of clinical trials for novel drug.
The global Biomarker of Disease market was valued at US$ 27750 million in 2023 and is anticipated to reach US$ 78390 million by 2030, witnessing a CAGR of 15.9% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Biomarker of Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarker of Disease.
The Biomarker of Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomarker of Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarker of Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aushon Biosystem
Bio-Rad Laboratories
Thermo Fisher Scientific Inc
Siemens AG
Eisai Co. Ltd
Roche Diagnostics Limited
Abbott Laboratories, Inc
Epistem Ltd
Ge Healthcare
Agilent Technologies Inc
Segment by Type
Sample Preparation
Assay Development
Biomarker Validation and Testing
Others
Segment by Application
Pharmaceutical Companies
Government & Private Research Institutes
Academic Institutes
Medical Device Manufacturing Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarker of Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarker of Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sample Preparation
1.2.3 Assay Development
1.2.4 Biomarker Validation and Testing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Biomarker of Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Government & Private Research Institutes
1.3.4 Academic Institutes
1.3.5 Medical Device Manufacturing Companies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarker of Disease Market Perspective (2019-2030)
2.2 Global Biomarker of Disease Growth Trends by Region
2.2.1 Global Biomarker of Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biomarker of Disease Historic Market Size by Region (2019-2024)
2.2.3 Biomarker of Disease Forecasted Market Size by Region (2025-2030)
2.3 Biomarker of Disease Market Dynamics
2.3.1 Biomarker of Disease Industry Trends
2.3.2 Biomarker of Disease Market Drivers
2.3.3 Biomarker of Disease Market Challenges
2.3.4 Biomarker of Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarker of Disease Players by Revenue
3.1.1 Global Top Biomarker of Disease Players by Revenue (2019-2024)
3.1.2 Global Biomarker of Disease Revenue Market Share by Players (2019-2024)
3.2 Global Biomarker of Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biomarker of Disease Revenue
3.4 Global Biomarker of Disease Market Concentration Ratio
3.4.1 Global Biomarker of Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarker of Disease Revenue in 2023
3.5 Global Key Players of Biomarker of Disease Head office and Area Served
3.6 Global Key Players of Biomarker of Disease, Product and Application
3.7 Global Key Players of Biomarker of Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarker of Disease Breakdown Data by Type
4.1 Global Biomarker of Disease Historic Market Size by Type (2019-2024)
4.2 Global Biomarker of Disease Forecasted Market Size by Type (2025-2030)
5 Biomarker of Disease Breakdown Data by Application
5.1 Global Biomarker of Disease Historic Market Size by Application (2019-2024)
5.2 Global Biomarker of Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biomarker of Disease Market Size (2019-2030)
6.2 North America Biomarker of Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biomarker of Disease Market Size by Country (2019-2024)
6.4 North America Biomarker of Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarker of Disease Market Size (2019-2030)
7.2 Europe Biomarker of Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biomarker of Disease Market Size by Country (2019-2024)
7.4 Europe Biomarker of Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarker of Disease Market Size (2019-2030)
8.2 Asia-Pacific Biomarker of Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biomarker of Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Biomarker of Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarker of Disease Market Size (2019-2030)
9.2 Latin America Biomarker of Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biomarker of Disease Market Size by Country (2019-2024)
9.4 Latin America Biomarker of Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarker of Disease Market Size (2019-2030)
10.2 Middle East & Africa Biomarker of Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biomarker of Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Biomarker of Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aushon Biosystem
11.1.1 Aushon Biosystem Company Details
11.1.2 Aushon Biosystem Business Overview
11.1.3 Aushon Biosystem Biomarker of Disease Introduction
11.1.4 Aushon Biosystem Revenue in Biomarker of Disease Business (2019-2024)
11.1.5 Aushon Biosystem Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Biomarker of Disease Introduction
11.2.4 Bio-Rad Laboratories Revenue in Biomarker of Disease Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Thermo Fisher Scientific Inc
11.3.1 Thermo Fisher Scientific Inc Company Details
11.3.2 Thermo Fisher Scientific Inc Business Overview
11.3.3 Thermo Fisher Scientific Inc Biomarker of Disease Introduction
11.3.4 Thermo Fisher Scientific Inc Revenue in Biomarker of Disease Business (2019-2024)
11.3.5 Thermo Fisher Scientific Inc Recent Development
11.4 Siemens AG
11.4.1 Siemens AG Company Details
11.4.2 Siemens AG Business Overview
11.4.3 Siemens AG Biomarker of Disease Introduction
11.4.4 Siemens AG Revenue in Biomarker of Disease Business (2019-2024)
11.4.5 Siemens AG Recent Development
11.5 Eisai Co. Ltd
11.5.1 Eisai Co. Ltd Company Details
11.5.2 Eisai Co. Ltd Business Overview
11.5.3 Eisai Co. Ltd Biomarker of Disease Introduction
11.5.4 Eisai Co. Ltd Revenue in Biomarker of Disease Business (2019-2024)
11.5.5 Eisai Co. Ltd Recent Development
11.6 Roche Diagnostics Limited
11.6.1 Roche Diagnostics Limited Company Details
11.6.2 Roche Diagnostics Limited Business Overview
11.6.3 Roche Diagnostics Limited Biomarker of Disease Introduction
11.6.4 Roche Diagnostics Limited Revenue in Biomarker of Disease Business (2019-2024)
11.6.5 Roche Diagnostics Limited Recent Development
11.7 Abbott Laboratories, Inc
11.7.1 Abbott Laboratories, Inc Company Details
11.7.2 Abbott Laboratories, Inc Business Overview
11.7.3 Abbott Laboratories, Inc Biomarker of Disease Introduction
11.7.4 Abbott Laboratories, Inc Revenue in Biomarker of Disease Business (2019-2024)
11.7.5 Abbott Laboratories, Inc Recent Development
11.8 Epistem Ltd
11.8.1 Epistem Ltd Company Details
11.8.2 Epistem Ltd Business Overview
11.8.3 Epistem Ltd Biomarker of Disease Introduction
11.8.4 Epistem Ltd Revenue in Biomarker of Disease Business (2019-2024)
11.8.5 Epistem Ltd Recent Development
11.9 Ge Healthcare
11.9.1 Ge Healthcare Company Details
11.9.2 Ge Healthcare Business Overview
11.9.3 Ge Healthcare Biomarker of Disease Introduction
11.9.4 Ge Healthcare Revenue in Biomarker of Disease Business (2019-2024)
11.9.5 Ge Healthcare Recent Development
11.10 Agilent Technologies Inc
11.10.1 Agilent Technologies Inc Company Details
11.10.2 Agilent Technologies Inc Business Overview
11.10.3 Agilent Technologies Inc Biomarker of Disease Introduction
11.10.4 Agilent Technologies Inc Revenue in Biomarker of Disease Business (2019-2024)
11.10.5 Agilent Technologies Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Biomarker of Disease Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Sample Preparation
Table 3. Key Players of Assay Development
Table 4. Key Players of Biomarker Validation and Testing
Table 5. Key Players of Others
Table 6. Global Biomarker of Disease Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Biomarker of Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Biomarker of Disease Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Biomarker of Disease Market Share by Region (2019-2024)
Table 10. Global Biomarker of Disease Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Biomarker of Disease Market Share by Region (2025-2030)
Table 12. Biomarker of Disease Market Trends
Table 13. Biomarker of Disease Market Drivers
Table 14. Biomarker of Disease Market Challenges
Table 15. Biomarker of Disease Market Restraints
Table 16. Global Biomarker of Disease Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Biomarker of Disease Market Share by Players (2019-2024)
Table 18. Global Top Biomarker of Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker of Disease as of 2023)
Table 19. Ranking of Global Top Biomarker of Disease Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Biomarker of Disease Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Biomarker of Disease, Headquarters and Area Served
Table 22. Global Key Players of Biomarker of Disease, Product and Application
Table 23. Global Key Players of Biomarker of Disease, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biomarker of Disease Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Biomarker of Disease Revenue Market Share by Type (2019-2024)
Table 27. Global Biomarker of Disease Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Biomarker of Disease Revenue Market Share by Type (2025-2030)
Table 29. Global Biomarker of Disease Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Biomarker of Disease Revenue Market Share by Application (2019-2024)
Table 31. Global Biomarker of Disease Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Biomarker of Disease Revenue Market Share by Application (2025-2030)
Table 33. North America Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Biomarker of Disease Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Biomarker of Disease Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Biomarker of Disease Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Biomarker of Disease Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Biomarker of Disease Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Biomarker of Disease Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Biomarker of Disease Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Biomarker of Disease Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Biomarker of Disease Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Biomarker of Disease Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Biomarker of Disease Market Size by Country (2025-2030) & (US$ Million)
Table 48. Aushon Biosystem Company Details
Table 49. Aushon Biosystem Business Overview
Table 50. Aushon Biosystem Biomarker of Disease Product
Table 51. Aushon Biosystem Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 52. Aushon Biosystem Recent Development
Table 53. Bio-Rad Laboratories Company Details
Table 54. Bio-Rad Laboratories Business Overview
Table 55. Bio-Rad Laboratories Biomarker of Disease Product
Table 56. Bio-Rad Laboratories Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 57. Bio-Rad Laboratories Recent Development
Table 58. Thermo Fisher Scientific Inc Company Details
Table 59. Thermo Fisher Scientific Inc Business Overview
Table 60. Thermo Fisher Scientific Inc Biomarker of Disease Product
Table 61. Thermo Fisher Scientific Inc Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 62. Thermo Fisher Scientific Inc Recent Development
Table 63. Siemens AG Company Details
Table 64. Siemens AG Business Overview
Table 65. Siemens AG Biomarker of Disease Product
Table 66. Siemens AG Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 67. Siemens AG Recent Development
Table 68. Eisai Co. Ltd Company Details
Table 69. Eisai Co. Ltd Business Overview
Table 70. Eisai Co. Ltd Biomarker of Disease Product
Table 71. Eisai Co. Ltd Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 72. Eisai Co. Ltd Recent Development
Table 73. Roche Diagnostics Limited Company Details
Table 74. Roche Diagnostics Limited Business Overview
Table 75. Roche Diagnostics Limited Biomarker of Disease Product
Table 76. Roche Diagnostics Limited Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 77. Roche Diagnostics Limited Recent Development
Table 78. Abbott Laboratories, Inc Company Details
Table 79. Abbott Laboratories, Inc Business Overview
Table 80. Abbott Laboratories, Inc Biomarker of Disease Product
Table 81. Abbott Laboratories, Inc Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 82. Abbott Laboratories, Inc Recent Development
Table 83. Epistem Ltd Company Details
Table 84. Epistem Ltd Business Overview
Table 85. Epistem Ltd Biomarker of Disease Product
Table 86. Epistem Ltd Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 87. Epistem Ltd Recent Development
Table 88. Ge Healthcare Company Details
Table 89. Ge Healthcare Business Overview
Table 90. Ge Healthcare Biomarker of Disease Product
Table 91. Ge Healthcare Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 92. Ge Healthcare Recent Development
Table 93. Agilent Technologies Inc Company Details
Table 94. Agilent Technologies Inc Business Overview
Table 95. Agilent Technologies Inc Biomarker of Disease Product
Table 96. Agilent Technologies Inc Revenue in Biomarker of Disease Business (2019-2024) & (US$ Million)
Table 97. Agilent Technologies Inc Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Biomarker of Disease Picture
Figure 2. Global Biomarker of Disease Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Biomarker of Disease Market Share by Type: 2023 VS 2030
Figure 4. Sample Preparation Features
Figure 5. Assay Development Features
Figure 6. Biomarker Validation and Testing Features
Figure 7. Others Features
Figure 8. Global Biomarker of Disease Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Biomarker of Disease Market Share by Application: 2023 VS 2030
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Government & Private Research Institutes Case Studies
Figure 12. Academic Institutes Case Studies
Figure 13. Medical Device Manufacturing Companies Case Studies
Figure 14. Others Case Studies
Figure 15. Biomarker of Disease Report Years Considered
Figure 16. Global Biomarker of Disease Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Biomarker of Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Biomarker of Disease Market Share by Region: 2023 VS 2030
Figure 19. Global Biomarker of Disease Market Share by Players in 2023
Figure 20. Global Top Biomarker of Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biomarker of Disease as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Biomarker of Disease Revenue in 2023
Figure 22. North America Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Biomarker of Disease Market Share by Country (2019-2030)
Figure 24. United States Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Biomarker of Disease Market Share by Country (2019-2030)
Figure 28. Germany Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Biomarker of Disease Market Share by Region (2019-2030)
Figure 36. China Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Biomarker of Disease Market Share by Country (2019-2030)
Figure 44. Mexico Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Biomarker of Disease Market Share by Country (2019-2030)
Figure 48. Turkey Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. UAE Biomarker of Disease Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Aushon Biosystem Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 53. Thermo Fisher Scientific Inc Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 54. Siemens AG Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 55. Eisai Co. Ltd Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 56. Roche Diagnostics Limited Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 57. Abbott Laboratories, Inc Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 58. Epistem Ltd Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 59. Ge Healthcare Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 60. Agilent Technologies Inc Revenue Growth Rate in Biomarker of Disease Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
